Compare Marsh & McLennan Companies, Inc. (MRSH) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Marsh & McLennan Companies, Inc. vs Nuwellis Inc — how do they compare? Marsh & McLennan Companies, Inc. trades at $180.6 (market cap $87.77B), while Nuwellis Inc trades at $2.95 (market cap $1.09M). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 80522.9× Nuwellis Inc's market cap, and Marsh & McLennan Companies, Inc. pays a 2.17% dividend while Nuwellis Inc pays none. Which is the better fit depends on your goals.
| MRSH | NUWE | |
|---|---|---|
Market Cap | $87.77B | $1.09M |
Sector | Financials | Technology |
52-Week High | $211.21 | $527.46 |
52-Week Low | $157.32 | $2.80 |
Enterprise Value | $108.61B | -$722.58K |
Dividend Yield | 2.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Marsh & McLennan Companies, Inc.
Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).
Read more on MRSH →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
